Top

European Journal of Medical Research

Published in:

Open Access 01-12-2023 | Intrauterine Insemination | Research

Pregnancy outcomes of intrauterine insemination in young patients with diminished ovarian reserve: a multicenter cohort study

Authors: Min Zhao, Qing Huan, Lisa Huang, Lin Yang, Meng Dong

Published in: European Journal of Medical Research | Issue 1/2023

Abstract

Background

To date, there is no consensus on whether intrauterine insemination (IUI) treatment is required in young patients with diminished ovarian reserve (DOR). Pregnancy outcomes in young DOR patients undergoing IUI are controversial. The existing studies are all single-center studies, with no existing multicenter cohort studies. The purpose of this multicenter study was to investigate the pregnancy outcomes of young DOR patients undergoing IUI.

Methods

This multicenter cohort study included a total of 4600 cycles in 2204 infertile patients who underwent IUI treatment in three reproductive medical centers between September 2018 and January 2022. The research subjects were divided into two groups according to their serum anti-Müllerian hormone (AMH) levels. Propensity score matching (PSM) was used to match the research subjects at a ratio of 1:4. The pregnancy outcomes in the two groups were compared.

Results

There was no significant difference in the clinical pregnancy rates (CPR), biochemical rates, and ectopic pregnancy rates between the two groups (P > 0.05). There were, however, significant differences in the miscarriage rates between the groups (P < 0.05). The live birth rates (LBR) were 6.6 vs. 9.9 between the two groups. The multivariable logistic regression models reveal that body mass index, AMH were significantly correlated with CPR; AMH were significantly correlated with LBR; BMI, follicle stimulating hormone were significantly correlated with miscarriage rate.

Conclusions

The clinical pregnancy rate of DOR patients was not significantly different from that of NOR patients; however, the miscarriage rates were significantly different from those of NOR patients.

Available only for authorised users

Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30:465–93. https://doi.org/10.1210/er.2009-0006.CrossRefPubMed

Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015: 103(3); e9–17. https://doi.org/10.1016/j.fertnstert.2014.12.093

Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. 2017;217:129–40. https://doi.org/10.1016/j.ajog.2017.02.027.CrossRefPubMed

Broer Simone L, Broekmans Frank JM, Laven Joop SE, Fauser Bart CJM. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688–701. https://doi.org/10.1093/humupd/dmu020.CrossRefPubMed

Busnelli A, Somigliana E, Cirillo F, Levi-Setti PE. Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis. Hum Reprod Update. 2021;27(6):973–88. https://doi.org/10.1093/humupd/dmab018.CrossRefPubMed

Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616–24. https://doi.org/10.1093/humrep/der092.CrossRefPubMed

Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452–3. https://doi.org/10.1016/j.fertnstert.2016.02.005.CrossRef

ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update. 2009;15:265–77. https://doi.org/10.1093/humupd/dmp003.CrossRef

Li HW, Yeung WS, Lau EY, Ho PC, Ng EH. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril. 2010;94(6):2177–81. https://doi.org/10.1016/j.fertnstert.2009.12.059.CrossRefPubMed

10.

Tiegs AW, Sun L, Scott RT Jr, Goodman LR. Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve. Fertil Steril. 2020;113(4):788-796.e4. https://doi.org/10.1016/j.fertnstert.2019.12.006.CrossRefPubMed

11.

Kaleli S, Kervancıoğlu ME, Erol N, Alakbarova U, Akşahin E, Öçer İF. Evaluating the efficacy of ovulation stimulation with intrauterine insemination in women with diminished ovarian reserve compared to women with normal ovarian reserve. Int J Gynaecol Obstet. 2022. https://doi.org/10.1002/ijgo.14325.CrossRefPubMed

12.

Wang MH, Chen CH, Wang CW, Hsu MI, Tzeng CR. A higher anti-Müllerian hormone level is associated with an increased chance of pregnancy in patients undergoing controlled ovarian stimulation and intrauterine insemination. J Obstet Gynaecol. 2015;35(1):64–8. https://doi.org/10.3109/01443615.2014.935718.CrossRefPubMed

13.

Dong Meng Wu, Shanshan ZX, Na Z, Jing Qi, Dandan Z, et al. Effects of COVID-19 vaccination status, vaccine type, and vaccination interval on IVF pregnancy outcomes in infertile couples. J Assist Reprod Genet. 2022;39(8):1849–59. https://doi.org/10.1007/s10815-022-02543-8.CrossRefPubMedPubMedCentral

14.

Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod. 2014;29(9):1842–5. https://doi.org/10.1093/humrep/deu139.CrossRefPubMed

15.

Sills ES, Alper MM, Walsh AP. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):30–6. https://doi.org/10.1016/j.ejogrb.2009.05.008.CrossRefPubMed

16.

Tobler KJ, Shoham G, Christianson MS, Zhao Y, Leong M, Shoham Z. Use of anti-mullerian hormone for testing ovarian reserve: a survey of 796 infertility clinics worldwide. J Assist Reprod Genet. 2015;32(10):1441–8. https://doi.org/10.1007/s10815-015-0562-7.CrossRefPubMedPubMedCentral

17.

Yun H, Jingyi Li, Fang Z, Liu Yifeng Xu, Gufeng GJ, et al. Factors affecting the live-birth rate in women with diminished ovarian reserve undergoing IVF-ET. Arch Gynecol Obstet. 2018;298(5):1017–27. https://doi.org/10.1007/s00404-018-4884-4.CrossRef

18.

Barroso G, Taylor S, Morshedi M, Manzur F, Gavino F, Oehninger S. Mitochondrial membrane potential integrity and plasma membrane translocation of phosphatidylserine as early apoptotic markers: a comparison of two different sperm subpopulations. Fertil Steril. 2006;85(1):149–54. https://doi.org/10.1016/j.fertn.stert.2005.06.046.CrossRefPubMed

19.

Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465–93. https://doi.org/10.1210/er.2009-0006.CrossRefPubMed

20.

Kim YJ, Park CW, Ku SY. Indications of intrauterine insemination for male and non-male factor infertility. Semin Reprod Med. 2014;32:301–12. https://doi.org/10.1055/s-0034-1375183.CrossRef

21.

Clémence S, Antoine G, Alix S, Thomas F, Fabien S, Bruno S. Results of in vitro fertilization versus intrauterine insemination in patients with low anti-Müllerian hormone levels. A single-center retrospective study of 639 + 119 cycles. J Gynecol Obstet Hum Reprod. 2021;50(3):101874. https://doi.org/10.1016/j.jogoh.2020.101874.CrossRef

22.

Banchhita S, Ozkan O, Paul S, Kannamannadiar J. Do ovarian reserve tests predict miscarriage in women undergoing assisted reproduction treatment? Eur J Obstet Gynecol Reprod Biol. 2010;153(2):181–4. https://doi.org/10.1016/j.ejogrb.2010.08.020.CrossRef

23.

Tingting L, Wen Z, Ningning P, Bing H, Rong Li, Caihong Ma. In vitro reproductive outcomes of fertilization and fresh embryo transfer in infertile women with adenomyosis: a retrospective cohort study. Front Endocrinol. 2022;13:865358. https://doi.org/10.3389/fendo.2022.865358.CrossRef

24.

Thum MY, El-Sheikhah A, Faris R, Parikh J, Wren M, Ogunyemi T, et al. The influence of body mass index to in-vitro fertilisation treatment outcome, risk of miscarriage and pregnancy outcome. J Obstet Gynaecol. 2007;27(7):699–702. https://doi.org/10.1080/01443610701612334.CrossRefPubMed

25.

Lyttle Schumacher BM, Jukic AMZ, Steiner AZ. Antimu¨llerian hormone as a risk factor for miscarriage in naturally conceived pregnancies. Fertil Steril. 2018;109:1065–71. https://doi.org/10.1016/j.fertnstert.2018.01.039.CrossRefPubMedPubMedCentral

26.

Kim HH. Markers of ovarian reserve: is it possible to estimate an ovarian age? Fertil Steril. 2017;108:950–1. https://doi.org/10.1016/j.fertnstert.2017.10.023.CrossRefPubMed

27.

Bunnewell SJ, Honess ER, Karia AM, Keay SD, Al Wattar BH, Quenby S. Diminished ovarian reserve in recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril. 2020;113:818–27. https://doi.org/10.1016/j.fertnstert.2019.11.014.CrossRefPubMed

28.

Katz-Jaffe MG, Surrey ES, Minjarez DA, Gustofson RL, Stevens JM, Schoolcraft WB. Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstet Gynecol. 2013;121:71–7. https://doi.org/10.1097/AOG.0b013e3182941ab0.CrossRefPubMed

29.

Shahine LK, Marshall L, Lamb JD, Hickok LR. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization. Fertil Steril. 2016;106:1124–8. https://doi.org/10.1016/j.fertnstert.2016.06.016.CrossRefPubMed

Title: Pregnancy outcomes of intrauterine insemination in young patients with diminished ovarian reserve: a multicenter cohort study
Authors: Min Zhao
Qing Huan
Lisa Huang
Lin Yang
Meng Dong
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Intrauterine Insemination
Miscarriage
Infertility
Infertility
Published in: European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI: https://doi.org/10.1186/s40001-023-01377-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pregnancy outcomes of intrauterine insemination in young patients with diminished ovarian reserve: a multicenter cohort study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

The direct prognosis comparison of 125I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer

Efficacy and safety of nonpharmacological strategies for the treatment of oligoasthenospermia: a systematic review and Bayesian network meta-analysis

Different COVID-19 treatments’ impact on hospital length of stay

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy

Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects

The association of asthma duration with body mass index and Weight-Adjusted-Waist index in a nationwide study of the U.S. adults